Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFα blocking agents in rheumatoid arthritis

Clinical Rheumatology

Volumn 27, Issue 1, 2008, Pages 91-95

  Benucci, Maurizio ^a   Saviola, Gianantonio ^b   Baiardi, Paola ^c   Cammelli, Emanuela ^a   Manfredi, Mariangela ^a  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b IRCCS Salvatore Maugeri   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Anti nucleosome antibodies; TNF blocking agents

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NUCLEOSOME ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; NUCLEOSOMES; PREDICTIVE VALUE OF TESTS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36549044498     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0728-5     Document Type: Article

References (26)

1. Lugher K, Mader AW, Richmond RK (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251-260
2. Flora PK, Gregory CD (1994) Recognition of apoptotic cells by human macrophages: Inhibition by monocyte/macrophage specific monoclonal antibody. Eur J Immunol 24:2625-2632
3. Berden JH, Licht R, van Bruggen MC, Tax WJ (1999) Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens 8:299-306
4. Benucci M, Li Gobbi F, Del Rosso A, Cesaretti S, Niccoli L, Cantini F (2003) Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 32(1):42-45
5. Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L et al (2004) Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Arthritis Rheum 43(1):76-84
6. D'Auria F, Rovere-Querini P, Giazzon M, Ajello P, Baldissera E, Manfredi AA, Sabbadini MG (2004) Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. J Intern Med 255(3):409-418
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324
8. Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN (2000) Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: Findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 43(11):2383-2390
9. Shakoor N, Michalska M, Harris CA, Block JA (2002) Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 359(9306):579-580
10. Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial. Arthritis Rheum 48(1):35-45
11. Van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, Van Roon JA (2006) Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. Rheumatology 45(10):1317-1319
12. De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F (2005) Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: Biologic and clinical implications in autoimmune arthritis. Arthritis Rheum 52(7):2192-2201
13. Eriksson C, Engstrand S, Sundqvist KG, Rantapaa-Dahlqvist S (2000) Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha. Ann Rheum Dis 064(3):403-407
14. Allanore Y, Sellam J, Batteux F, Job Deslandre C, Weill B, Kahan A (2004) Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab. Clin Exp Rheumatol 22(6):756-758
15. Caramaschi P, Biasi D, Colombatti M, Pieropan S, Martinelli N, Carletto A, Volpe A, Pacor LM, Bambara LM (2006) Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int 26(3):209-214
16. Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ (2006) Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with long term infliximab therapy. J Rheumatol 33(1):24-30
17. Priori R, Alessandri C, Magrini L, Cassarà EAM, Modesti MG, Mancini R, Valesini G (2006) Autoantibodies appearance in patients with rheumatoid arthritis undergoing treatment with adalimumab: Is there a role for nucleosome serum accumulation? Ann Rheum Dis SII:497-498
18. Lugering A, Schmidt M, Lugering N, Pauels HG, Domschke W, Kucharzik T (2001) Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 121(5):1145-1157
19. Ten Hove T, Van Mtfrans C, Peppelenbosch MP, Van Deventer SJ (2002) Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 50(2):206-211
20. Van den Brande JM, Braat H, van den Brink GR, Versteeg HH, Bauer CA, Hoedemaeker I, van Montfrans C, Hommes DW, Peppelenbosch MP, van Deventer SJ (2003) Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124(7):1774-1785
21. Grodzicky T, Elkon KB (2000) Apoptosis in rheumatic diseases. Am J Med 108(1):73-82 (Review)
22. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46(1):191-201
23. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19(1):56-59
24. Rovere P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, Zimmermann VS, Garlanda C, Fascio U, Sabbadini MG, Rugarli C, Mantovani A, Manfredi AA (2000) The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96(13):4300-4306
25. Cairns AP, Duncan MKJ, Hinder AE, Taggart AJ (2002) New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis. Ann Rheum Dis 61:1031-1032
26. Cairns AP, Crockard AD, McConnell JR, Courtney PA, Bell AL (2001) Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: Relations with apoptotic neutrophils and disease activity. Ann Rheum Dis 60:950-955